Variable | Result | Missing data |
---|---|---|
Pre-hospital treatments (N, %, 95 % CI) | ||
Oxygen | 585, 58.1 % (55.4–61.5 %) | 8 (0.8 %) |
Inhaled beta-agonist | 216, 21.4 % (18.9–24 %) | 15 (1.5 %) |
Nitrates | 128, 12.9 % (10.9–15.1 %) | 12 (1.2 %) |
Aspirin | 105, 10.6 % (8.8–12.7 %) | 15 (1.5 %) |
Inhaled anticholinergic | 87, 9 % (7.4–11 %) | 43 (4.3 %) |
IV beta-agonist | 26, 2.6 % (1.8–3.8 %) | 17 (1.7 %) |
Corticosteroid | 26, 2.6 % (1.8–3.8 %) | 17 (1.7 %) |
Opiate (morphine or fentanyl) | 26, 2.6 % (1.8–3.8 %) | 16 (1.6 %) |
IV fluids | 20, 2.1 % (1.3–3.2 %) | 43 (4.3 %) |
Non-invasive ventilation | 18, 1.8 % (1.2–2.9 %) | 16 (1.6 %) |
Diuretic | 18, 1.8 % (1.2–2.9 %) | 16 (1.6 %) |
Adrenaline | 9, 0.9 % (0.5–1.7 %) | 16 (1.6 %) |
Endotracheal intubation | 0, 0 % (0–0.4 %) | 16 (1.6 %) |
Thrombolysis | 0, 0 % (0–0.4 %) | 16 (1.6 %) |
ED diagnosis (N, %, 95 % CI) | ||
Lower respiratory tract infection (including pneumonia) | 229, 22.7 % (20.2–25.4 %) | 0 |
Cardiac failure | 204, 20.3 % (17.9–22.9 %) | 0 |
COPD | 198, 19.7 % (17.3–22.2 %) | 0 |
Asthma | 79, 7.9 % (6.3–9.7 %) | 0 |
Acute coronary syndrome | 28, 2.8 % (1.9–4 %) | 0 |
Atrial fibrillation | 27, 2.7 % (1.9–3.9 %) | 0 |
Hyperventilation | 16, 1.6 % (1–2.6 %) | 0 |
Pleural effusion | 15, 1.5 % (0.9–2.4 %) | 0 |
Malignancy | 14, 1.4 % (0.8–2.3 %) | 0 |
Pulmonary embolism | 12, 1.2 % (0.7–2.1 %) | 0 |
Pneumothorax | 4, 0.4 % (0.2–1 %) | 0 |
Other/ unclear | 181, 18 % (15.7–20.5 %) | 0 |
Final hospital diagnosis (N, %, 95 % CI) | ||
Lower respiratory tract infection (including pneumonia) | 236, 23.4 % (20.9–26.2 %) | 0 |
Cardiac failure | 186, 18.5 % (16.2–21 %) | 0 |
COPD | 197. 19.6 % (17.2–22.1 %) | 0 |
Asthma | 76, 7.6 % (6.1–9.3 %) | 0 |
Acute coronary syndrome | 29, 2.9 % (2–4.1 %) | 0 |
Atrial fibrillation | 21, 2.1 % (1.4–3.2 %) | 0 |
Hyperventilation | 15, 1.5 % (0.9–2.4 %) | 0 |
Pleural effusion | 11, 1.1 % (0.6–1.9 %) | 0 |
Malignancy | 18, 1.8 % (1.1–2.8 %) | 0 |
Pulmonary embolism | 9, 0.9 % (0.5–1.7 %) | 0 |
Pneumothorax | 4, 0.4 % (0.2–1 %) | 0 |
Other/ unclear | 205, 20.4 % (18–23 %) | 0 |